Adaptive Biotechnologies (ADPT) Income from Non-Controlling Interests (2021 - 2025)
Historic Income from Non-Controlling Interests for Adaptive Biotechnologies (ADPT) over the last 5 years, with Q3 2025 value amounting to -$1000.0.
- Adaptive Biotechnologies' Income from Non-Controlling Interests rose 9615.38% to -$1000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $17000.0, marking a year-over-year increase of 11634.62%. This contributed to the annual value of -$103000.0 for FY2024, which is 9074.07% down from last year.
- Per Adaptive Biotechnologies' latest filing, its Income from Non-Controlling Interests stood at -$1000.0 for Q3 2025, which was up 9615.38% from $21000.0 recorded in Q2 2025.
- In the past 5 years, Adaptive Biotechnologies' Income from Non-Controlling Interests registered a high of $76000.0 during Q4 2021, and its lowest value of -$95000.0 during Q3 2021.
- In the last 5 years, Adaptive Biotechnologies' Income from Non-Controlling Interests had a median value of -$26000.0 in 2023 and averaged -$18294.1.
- As far as peak fluctuations go, Adaptive Biotechnologies' Income from Non-Controlling Interests plummeted by 250000.0% in 2024, and later skyrocketed by 18461.54% in 2025.
- Quarter analysis of 5 years shows Adaptive Biotechnologies' Income from Non-Controlling Interests stood at $76000.0 in 2021, then plummeted by 153.95% to -$41000.0 in 2022, then surged by 36.59% to -$26000.0 in 2023, then increased by 3.85% to -$25000.0 in 2024, then surged by 96.0% to -$1000.0 in 2025.
- Its Income from Non-Controlling Interests stands at -$1000.0 for Q3 2025, versus $21000.0 for Q2 2025 and $22000.0 for Q1 2025.